The demand for the Global Surgical Mask and Respirator Market is anticipated to increase in the coming years which is primarily attributed to the increasing number of surgeries due to increasing prevalence of chronic disorders.
According to the latest report published by DelveInsight Surgical Mask and Respirator Market Insight, Competitive Landscape & Market Forecast 2027, the Global Surgical Mask and Respirator Market are expected to witness appreciable growth in product demand owing to various reasons, such as a surge in epidemic and pandemic outbreaks will increase the overall Surgical Mask and Respirator Market as these devices are used to prevent the transmission of the virus.
Interested in knowing how the Surgical Mask and Respirator market is expected to grow by 2027? Click to get a snapshot of the Surgical Mask and Respirator Market Sample Report
Surgical Mask and Respirator Overview
A Surgical Mask and Respirator is intended for medical purposes that cover the user’s nose and mouth and provides a physical barrier to fluids and particulate materials. Surgical masks are Class II medical devices. Respirators include filtering facepiece respirators (FFRs) such as N95s which filter at least 95 percent of airborne particles. Respirator provides certain filtration efficiency levels to help reduce wearer exposure to pathogenic particles in a health care setting.
Surgical Mask and Respirator Market Insights
North America is expected to occupy a major share in the overall Surgical Mask and Respirator market in the forthcoming years. This domination can be due to a surging number of surgical procedures and the rising prevalence of chronic disorders and the rising prevalence of airborne diseases will propel the Surgical Mask and Respirator market in North America. Additionally, growing awareness among the population regarding the use of protective gear after the pandemic will also increase the demand for surgical mask and respirator in North America, leading to a rise in the overall Surgical Mask and Respirator market growth.
For further information about the scenario of the Surgical Mask and Respirator market in other geographies, visit Surgical Mask and Respirator Market
Recent Developments in the Surgical Mask and Respirator Market:
- In January 2022, NIOSH approved six N95 respirators. Six respirators includes the companies 3M Aura Particulate Respirator, Harley N95 Mask, Fangtian N95 Face Mask, Honeywell Surgical N95 Respirator, Maxboost N95 Mask, and MedicPro N95 Face Mask.
- In August 2020, Cardinal Health, a multinational health care services company, in collaboration with ClearMask, one of the innovator in surgical mask field, introduced the world’s first fully transparent surgical mask approved by FDA, for hassle-free speech gesture and communication.
- In March 2020, Honeywell International Inc, one of the major innovator and manufacturer in healthcare industry, announced that they have expanded its capacity of production for N95 masks and started a new operation in Phoenix on government call.
- In March 2020, 3M, one of the operator n the fields of industry, worker safety, U.S. health care, and consumer goods, and Ford Motor Company are partnering to increase the production of 3M’s powered air-purifying respirators, or PAPRs.
For more insights; download the snapshot of the key highlights covered in the Surgical Mask and Respirator Market Analysis
Key Players in the Surgical Mask and Respirator Market
Some of the leading Surgical Mask and Respirator Market players operating in the Surgical Mask and Respirator market include 3M, Moldex-Metric., Kwalitex Healthcare Pvt Ltd, Cartel Healthcare Pvt. Ltd., Magnum Health And Safety Pvt. Ltd, Mediblue Healthcare Private Limited., Medline Industries Inc., Plasti Surge Industries Pvt. Ltd, Premium Health Care Disposables Private Limited, Thea-Tex Healthcare (India) Pvt. Ltd, Honeywell International Inc., Ambu A/S., ALPHAPROTECH, Teleflex Incorporated., Detmold Group, uvex group, MSA, RZ Industries, Makrite, SHIGEMATSU WORKS CO., LTD., and others.
Surgical Mask and Respirator Market Dynamics
The Surgical Mask and Respirator Market is slated towards positive market growth due to factors such as the increasing number of surgeries, and surge in epidemic and pandemic outbreaks. Also, increasing prevalence of airbone and respiratory disorders due to excess exposure to pollution and chemicals across the world are anticipated to bolster the Surgical Mask and Respirator Market. Moreover, the product launches as well as approval, in turn, drive the product demand in the Surgical Mask and Respirator Market. Additionally, owing to the various advantages and applications as well as new approvals in the demand for N-series respiratory will drive the Surgical Mask and Respirator Market growth
The ongoing COVID-19 pandemic has significantly increased the Surgical Mask and Respirator Market as they were used to prevent the transmission of the coronavirus. Owing to this fact, the leading Surgical Mask and Respirator market players accelerated their production of surgical mask and respirators. However, during the onset of pandemic the industries were shut down due to strict lockdown rules which decreased the supply of the device in the market. This lead to the elevation of the price of masks and respirators. But, with the return of normalcy, resources and raw materials and with the increasing demand the key players resumed the manufacturing of the device, thereby increasing the Surgical Mask and Respirator market demand in turn, propelling the growth of Surgical Mask and Respirator Market.
However, highly competitive pricing of surgical mask and respirator and it’s raw material may hamper the Surgical Mask and Respirator Market growth.
Get a sneak peek at the market dynamics @ Surgical Mask and Respirator Market Dynamics Analysis
Scope of the Surgical Mask and Respirator Market Report
- Coverage: Global
- Study Period: 2019-2027
- Market Segmentation By Product Type – Surgical Mask (Basic Surgical Mask, Anti-Fog Surgical Mask, Fluid Or Splash Resistant Surgical Mask, And Others) And Respirator (N- Series, P- Series, And R- Series)
- Market Segmentation By Usability Type – Disposable And Reusable
- Market Segmentation By Distribution Channel– Hospital & Clinical Pharmacy, E-Commerce, And Others
- Market Segmentation By Geography – North America, Europe, Asia-Pacific, and Rest of World
- Key Surgical Mask and Respirator Companies – 3M, Moldex-Metric., Kwalitex Healthcare Pvt Ltd, Cartel Healthcare Pvt. Ltd., Magnum Health And Safety Pvt. Ltd, Mediblue Healthcare Private Limited., Medline Industries Inc., Plasti Surge Industries Pvt. Ltd, Premium Health Care Disposables Private Limited, Thea-Tex Healthcare (India) Pvt. Ltd, Honeywell International Inc., Ambu A/S., ALPHAPROTECH, Teleflex Incorporated., Detmold Group, uvex group, MSA, RZ Industries, Makrite, SHIGEMATSU WORKS CO.,LTD., and others.
- Porter’s Five Forces Analysis, Product Profiles, Case Studies, KOL’s Views, Analyst’s View
Which MedTech player is set to emerge as the trendsetter explore @ Key Surgical Mask and Respirator Companies
Table of Contents
1 | Report Introduction |
2 | Executive summary |
3 | Regulatory and Patent Analysis |
4 | Surgical Mask and Respirator Market Key Factors Analysis |
5 | Porter’s Five Forces Analysis |
6 | COVID-19 Impact Analysis on Surgical Mask and Respirator Market |
7 | Surgical Mask and Respirator Market Layout |
8 | Surgical Mask and Respirator Global Company Share Analysis – Key 3-5 Companies |
9 | Market Company and Product Profiles |
10 | Project Approach |
Learn more about the Surgical Mask and Respirators @ Surgical Mask and Respirator Regulatory And Patent Analysis
Related Reports
Chronic Obstructive Pulmonary Disease (COPD) Market
DelveInsight’s, “Chronic Obstructive Pulmonary Disease Pipeline Insight, 2021,” report provides comprehensive insights about 50+ companies and 50+ pipeline drugs in the Chronic Obstructive Pulmonary Disease pipeline landscape. It covers the pipeline drug profiles, including clinical and non-clinical stage products, and key Chronic Obstructive Pulmonary Disease companies involved like GlaxoSmithKline, Sanofi, Chiesi Farmaceutici S.p.A, United Therapeutics Corporation, Verona Pharma plc, AstraZeneca, Immunotek, Novartis, Genentech, Vertex Pharmaceuticals, Glenmark Pharmaceuticals, EmeraMed, Afimmune, 3SBio, OmniSpirant, Rhizen Pharmaceuticals, Foresee Pharmaceuticals, Brickell Biotech and many more.
DelveInsight’s ‘Pulse Oximeters – Market Insights, Competitive Landscape and Market Forecast 2027’ report delivers an in-depth understanding of Pulse Oximeters, historical and forecasted Pulse Oximeters market trends, market drivers, market barriers and key Pulse Oximeters companies involved like Medtronic, Nonin Medical Inc, Lepu Medical Technology, TytoCare Ltd, VYAIRE, OMRON Corporation. Meditech Equipment Co ., Ltd, and several others.
DelveInsight’s Airway Stent – Market Insight, Competitive Landscape, and Market Forecast, 2027 report delivers an in-depth understanding of the market and Competitive Landscape analysis. Key Airway stents companies involved in this market include Boston Medical Products, TAEWOONG Medical Co., Boston Scientific Corporation, Novatech SA, among others
Artificial Lung Devices Pipeline
DelveInsight’s, “Artificial Lung Devices–Pipeline Insight and Competitive Landscape, 202,” report provides comprehensive insights about 20+ companies and 23+ pipeline devices in the artificial lung devices pipeline landscape which includes key artificial lung devices companies like Lung Biotechnology, Miromatrix, Charles Stark Draper Laboratory Inc, United Therapeutics Corporation, XVIVO Perfusion, Medtronic, Getinge, Xenios AG, ALung Technologies Inc., MC3 Cardiopulmonary, Abiomed and many more.
“DelveInsight’s ‘Cough Assist Devices – Market Insight, Competitive Landscape and Market Forecast, 2027’ report delivers an in-depth understanding of Cough Assist Devices and the historical and forecasted Cough Assist Devices market trends, market drivers & barriers, unmet needs and key Cough Assist Devices companies involved such as Koninklijke Philips N.V, Percussionaire Corp., Emerson, Hill Rom, Dima Italia SRL, and many more.
Acute Respiratory Distress Syndrome Pipeline
DelveInsight’s, “Acute Respiratory Distress Syndrome Pipeline Insight, 2022,” report provides comprehensive insights about 60+ companies and 60+ pipeline drugs in the Acute Respiratory Distress Syndrome pipeline landscape. It covers the pipeline drug profiles, including clinical and non-clinical stage products and key Acute Respiratory Distress Syndrome companies involved like Faron Pharmaceuticals, BioMarck Pharmaceuticals, Athersys, Apeiron Biologics, Cynata Therapeutics, Orbsen Therapeutics, GEn1E Lifesciences, Exvastat, Longeveron, CohBar, ZyVersa Therapeutics, Abbreos, Aviceda Therapeutics, ImStem Biotechnology, Bayer and many more.
Interstitial Lung Diseases Pipeline
DelveInsight’s, “Interstitial Lung Diseases Pipeline Insight, 2022,” report provides comprehensive insights about 100+ companies and 100+ pipeline drugs in the Interstitial Lung Disease pipeline landscape. It covers the pipeline drug profiles, including clinical and non-clinical stage products and key Interstitial Lung Disease companies involved like AdAlta, Bristol-Myers Squibb, aTyr Pharma, Avalyn Pharmaceuticals, Beijing Continent Pharmaceutical, Regend Therapeutics, Reata Pharmaceuticals, FibroGen, PureTech Health, Bellerophon Pulse Technologies, OncoArendi Therapeutics, LTT Bio-Pharma, EmphyCorp, Genentech, Blade Therapeutics, Acceleron Pharma and many more.
Interested to know more about the breakthrough happenings? Take a look at the posts below
- Alarming Growth of Chronic Respiratory Diseases and Their Prolonged Impact on the Quality of Life
- Asthma: Rising Prevalence And The Key Challenges In The Management
- Chronic Refractory Cough Market and the Monopoly of the Over-The-Counter Drugs
About DelveInsight
DelveInsight is a leading Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
Contact Us
Kunjika Agarwal
info@delveinsight.com
+1(919)321-6187